N/A
Manufactured by Mission Pharmacal Company
1,767 FDA adverse event reports analyzed
Last updated: 2026-04-15
METHYL SALICYLATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Mission Pharmacal Company. The most commonly reported adverse reactions for METHYL SALICYLATE include PRURITUS, HYPERTENSION, DRUG INEFFECTIVE, PNEUMONIA, DYSPEPSIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for METHYL SALICYLATE.
Out of 219 classified reports for METHYL SALICYLATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 1,767 FDA FAERS reports that mention METHYL SALICYLATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include PRURITUS, HYPERTENSION, DRUG INEFFECTIVE, PNEUMONIA, DYSPEPSIA, OFF LABEL USE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Mission Pharmacal Company in connection with METHYL SALICYLATE. Always verify the specific product and NDC with your pharmacist.